What Are Normal Homocysteine Levels by Age?

Most laboratories flag homocysteine as “normal” when it falls between about 5 and 15 µmol/L in the blood, but the number that is actually typical for you depends heavily on your age and sex.¹ Young children run well below that range, teenagers land somewhere in the middle, and older adults often creep above the conventional cutoff without any obvious deficiency. The story is more layered than a single reference range can capture, and some of the thresholds that matter for health sit lower than the number printed on your lab report.

Children and Adolescents Start Low

In early childhood, homocysteine levels are quite low. A study tracking children and adolescents found that average levels rose from about 3.8 µmol/L in the youngest children to roughly 8.7 µmol/L in older teenagers, a steady climb that tracks with growth and the natural decline in circulating folate and vitamin B12 that happens as kids age.² Folate levels, which help the body recycle homocysteine, were roughly twice as high in the youngest children compared with teenagers in that same study, which goes a long way toward explaining the gap.

Because children naturally have lower levels, applying the standard adult cutoff of 15 µmol/L to a teenager would miss potentially meaningful elevations. Research on adolescents has proposed that the 90th percentile in that age group falls around 8.2 µmol/L, which could serve as a more age-appropriate flag for elevated homocysteine.³ In practice, pediatricians rarely test homocysteine unless there is a suspicion of a genetic metabolic disorder, but the point is that “normal” for a twelve-year-old looks nothing like “normal” for a fifty-year-old.

Adult Levels and the Sex Gap

Once you reach adulthood, the pattern shifts: men consistently run higher than women. In a large cross-sectional study of the Chinese general population, the median homocysteine was 12.5 µmol/L in men and 9.1 µmol/L in women.⁴ U.S. data from the post-folic-acid-fortification era show the same direction: men had significantly higher levels than women in every decade from 19 through 70.⁵ In a study from the Jackson Heart Study, men at age 50 averaged about 9.9 µmol/L compared with roughly 8.4 µmol/L for women, a gap of more than 1.5 µmol/L that persisted across all age groups.⁶

One reason for the sex gap is estrogen. In premenopausal women, estrogen appears to help keep homocysteine in check. As women transition through menopause and estradiol levels fall, homocysteine rises in step. Research measuring women across menopausal stages found a clear inverse relationship: lower estradiol correlated with higher homocysteine.⁷ Interestingly, synthetic estrogen use has opposite effects depending on menopausal status. In premenopausal women taking estrogen alone, homocysteine was on average about 1.15 µmol/L higher, while in postmenopausal women using estrogen alone, it was about 0.86 µmol/L lower compared with non-users.⁸ The mechanisms behind that reversal are still being studied, but the practical implication is that hormone therapy in menopause may partly offset the postmenopausal rise.

The Rise After 50

For both sexes, homocysteine tends to dip to its lowest point somewhere between age 30 and 50, then rises significantly afterward. In the Chinese cross-sectional study, average levels in men under 30 and over 60 actually exceeded the 15 µmol/L upper limit of the “normal” range.⁹ Among elderly populations, even the 65-to-69 group runs noticeably lower than the 70-to-74 group: one study of older adults found median levels roughly 1 µmol/L higher in the older bracket.¹⁰

A key driver behind this age-related climb is declining B-vitamin status. The body converts homocysteine back into other amino acids using folate, vitamin B12, and vitamin B6 as essential helpers.¹¹ Older adults absorb vitamin B12 less efficiently because of a high prevalence of atrophic gastritis, a condition in which the stomach lining thins and produces less acid, making it harder to free B12 from food.¹² Kidney function also declines with age, and the kidneys play a role in clearing homocysteine. One study found that people with higher homocysteine levels had roughly 2.7 times the odds of chronic kidney disease after adjusting for other risk factors, using a cutoff of about 15.15 µmol/L.¹³

An interesting nuance: when one study compared elderly and younger subjects and then adjusted for B-vitamin concentrations, the age-related difference in homocysteine essentially disappeared.¹⁴ In other words, much of the “aging” effect on homocysteine may really be a vitamin-status effect that happens to get worse with age. That distinction matters because it suggests the rise is at least partly preventable.

Pregnancy Drops Levels Substantially

Pregnant women are a major exception to normal adult ranges. Homocysteine falls in all three trimesters compared with non-pregnant levels. In one study, non-pregnant women averaged about 7.9 µmol/L, while the same group during pregnancy dropped to 5.6 µmol/L in the first trimester and bottomed out around 4.3 µmol/L in the second trimester before edging back up to about 5.5 µmol/L near delivery.¹⁵ The decreases were statistically significant across all trimesters, and folic acid supplementation pushed levels even lower.

A Chinese longitudinal study proposed trimester-specific reference ranges: roughly 4.4 to 10.2 µmol/L in the first trimester, 3.4 to 8.6 µmol/L in the second, and 3.8 to 11.2 µmol/L in the third.¹⁶ If your doctor is monitoring homocysteine during pregnancy, applying the standard 5-to-15 adult range would be misleading. A reading of 12 µmol/L that looks unremarkable for a non-pregnant adult could be unusually high for someone in their second trimester.

Genetics Can Shift Your Baseline

One well-studied genetic variant affects an enzyme called MTHFR, which helps convert folate into a form the body uses to recycle homocysteine. People who carry two copies of the C677T variant (the TT genotype) tend to have higher homocysteine than those with the common CC genotype.¹⁷ The same pattern has been confirmed in elderly populations, where median levels were about 10.7 µmol/L in the TT group compared with 9.6 µmol/L in the CC group.¹⁰

The TT genotype is not rare. Depending on ethnicity, somewhere between 10 and 25 percent of the population carries it. For these individuals, even adequate folate intake may not keep homocysteine as low as it would in someone with the CC genotype, though higher-than-average folate consumption can usually compensate. If your homocysteine is persistently above where your age and sex peers land and your B-vitamin levels look fine, MTHFR status is one of the usual suspects clinicians consider.

Why Elevated Homocysteine Matters for Health

The standard lab range tops out at 15 µmol/L, but growing evidence suggests that health risks start accumulating well before that ceiling. A meta-analysis of prospective studies found that for every 5 µmol/L increase in homocysteine, coronary heart disease mortality rose by about 52 percent, cardiovascular mortality by about 32 percent, and all-cause mortality by about 27 percent.¹⁸ Those risks were most pronounced in elderly populations. A more recent cohort study using U.S. NHANES data found that even people in the middle homocysteine tertile (roughly 9.3 to 12.5 µmol/L) had modestly increased all-cause mortality compared with the lowest group, and the highest tertile (above 12.5 µmol/L) had about 64 percent higher risk of death from any cause.¹⁹ The researchers specifically noted that elevated levels were associated with increased risk even below the conventional 15 µmol/L threshold.

Coronary artery calcification, a marker of plaque buildup, has also been linked to homocysteine. In a study of over a thousand participants, the relationship was strongest in people at intermediate risk for heart disease, independent of traditional risk factors like cholesterol and blood pressure.²⁰

Brain Health and Dementia

An international consensus statement concluded that moderately elevated homocysteine, defined as above 11 µmol/L, is a modifiable risk factor for cognitive decline, dementia, and Alzheimer’s disease.²¹ That 11 µmol/L figure is well within the “normal” lab range, which underscores how the standard reference range and the optimal health range may not be the same thing. In the Framingham Study, people with homocysteine above 14 µmol/L had nearly double the risk of developing Alzheimer’s disease, and the risk rose continuously with higher levels.²² More recent work has confirmed that people in the highest homocysteine group who already had mild cognitive impairment were about 2.25 times more likely to progress to dementia compared with those in the lowest group.²³

Bone Health

A large prospective study published in the New England Journal of Medicine found that people in the highest age-specific quartile of homocysteine had about 1.9 times the fracture risk, independent of bone mineral density and other known risk factors.²⁴ The mechanism appears to involve oxidative stress and degradation of the proteins that form the structural scaffold of bone.²⁵ In older women in the U.S., elevated homocysteine was associated with more than double the odds of lumbar osteoporosis.²⁶ This is a risk factor many people are unaware of, since discussions about bone health tend to focus on calcium and vitamin D rather than homocysteine.

Lifestyle Factors That Move the Needle

Your daily habits influence where you land within the normal range. A population-based study of over 3,000 Dutch adults found that smoking, coffee consumption, and alcohol intake were among the strongest lifestyle predictors. Smoking and heavy coffee drinking were associated with higher homocysteine, while moderate alcohol consumption was linked to slightly lower levels. The estimated impact of any single lifestyle change ranged from about 0.1 to 1.7 µmol/L, which may not sound like much but is meaningful at a population level, especially given the continuous dose-response relationship between homocysteine and health outcomes.²⁷ The smoking effect was most prominent in women, and the alcohol effect was strongest in men.

Heavy alcohol use is a separate story from moderate consumption. In people with alcohol dependence, homocysteine tends to be elevated, and there is evidence of a self-reinforcing loop: higher homocysteine may intensify craving, which drives more drinking, which raises homocysteine further.²⁸ So the relationship with alcohol is not linear: moderate amounts trend favorable, but heavy or dependent-level drinking pushes homocysteine up.

Medications That Can Raise Homocysteine

Several common prescription drugs interfere with homocysteine metabolism in ways that may go unnoticed. Metformin, one of the most widely prescribed diabetes medications, can impair B12 absorption in the gut, which in turn raises homocysteine. Fibrate-type cholesterol drugs and niacin can do the same through interference with folate pathways. Cholestyramine, used for high cholesterol, disrupts vitamin absorption as well.²⁹ The irony is real: drugs prescribed to reduce cardiovascular risk may simultaneously raise a marker associated with cardiovascular harm.

Neurological medications are another common culprit. Levodopa, the mainstay treatment for Parkinson’s disease, and several antiepileptic drugs are linked to elevated homocysteine.³⁰ In epileptic patients on long-term anticonvulsant therapy, especially those taking multiple drugs for more than seven years, folate deficiency was common and their homocysteine levels exceeded the 90th percentile of healthy controls.³¹ If you take any of these medications long-term, periodic monitoring of B-vitamin levels and homocysteine is worth discussing with your doctor.

Lowering Homocysteine With B Vitamins: What the Trials Actually Show

Given all the observational data linking high homocysteine to heart disease, dementia, and fractures, you would expect that bringing it down with supplements would reduce those risks. The supplement part works well: B-vitamin supplementation reliably lowers homocysteine by about 25 percent on average.³² The disappointment is in the outcomes.

The HOPE-2 trial, one of the largest to test this directly, gave folic acid plus B6 and B12 to patients with existing vascular disease and reduced their homocysteine by about 2.4 µmol/L. But the rate of heart attacks, strokes, and cardiovascular deaths was virtually identical between the treatment and placebo groups.³³ The mega-meta-analysis pooling eight trials with over 37,000 participants confirmed the same non-result: no significant effect on major vascular events, coronary events, or stroke despite sustained homocysteine reduction maintained for an average of five years.³²

This disconnect remains one of the genuine puzzles in cardiovascular research. One possibility is that homocysteine is a marker of B-vitamin deficiency or poor metabolic health rather than a direct cause of damage, so lowering the number without fixing the underlying problem does not help. Another is that the trials enrolled people who already had advanced disease, and the intervention came too late to reverse years of accumulated vascular damage. A recent review noted that B vitamins do reduce homocysteine effectively and that lower levels are associated with reduced thromboembolic risk in observational data, but conceded that whether supplementation actually produces clinical benefits remains inconclusive.³⁴ The dementia picture is slightly more encouraging: the consensus statement on homocysteine and dementia noted that B-vitamin treatment markedly slowed brain atrophy and cognitive decline in elderly people who already had cognitive impairment, though these findings need replication in larger prevention trials.²¹

When You Get Tested, Timing Matters

If you are comparing your homocysteine result to any reference range, it helps to know that fasting status can shift the number. In a large Norwegian study, people who had not eaten for six or more hours before blood draw had significantly higher homocysteine than those who had eaten recently: about 11.7 versus 11.2 µmol/L in men, and 10.2 versus 9.7 µmol/L in women.³⁵ The difference is modest, but it is consistent and statistically significant. In most groups, the longer the time since the last meal, the higher the reading trended. If you have been fasting overnight for a morning blood draw, your result may run half a µmol/L or so higher than it would after lunch. That matters if you are tracking changes over time or if your result lands right near a borderline.

Most physicians do not specifically require fasting for a homocysteine test the way they do for glucose or a standard lipid panel, but knowing whether you fasted can help put the result in context. If you are comparing results from two different visits, ideally both were drawn under similar conditions.